June 30, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
FDA authorizes marketing of risk modification claim on Zyn nicotine pouches
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press release, marketing of these products can now include the modified risk claim that “using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic
646 words~3 min read
